Melanoma therapy tied to cutaneous adverse events
(HealthDay)—Anti-programmed cell death (PD)-1 therapy for metastatic melanoma is associated with the development of immune-related cutaneous events, according to research published in the March issue of the Journal of the ...
Mar 16, 2016
0
3